Skip to main content
Oscar (Gomez-Duarte) Gomez, MD, Pediatric Infectious Disease, Charlotte, NC

OscarGilberto(Gomez-Duarte)GomezMD

Pediatric Infectious Disease Charlotte, NC

Chief of Pediatric Infectious Diseases and Associate Professor of Pediatrics, University at Buffalo, State University of New York

Dr. Gomez is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Gomez's full profile

Already have an account?

  • Office

    1001 Blythe Blvd
    Medical Center Plaza Suite 200
    Charlotte, NC 28203
    Phone+1 704-381-8840
    Fax+1 716-323-0296

Summary

  • I am a physician scientist with PhD in microbiology and immunology and clinical training in pediatrics and pediatric infectious diseases. My overall goal is to help decrease the morbidity and mortality of childhood infections through excellence in research, education and patient care. As chief of the Division of Infectious Diseases in the Department of Pediatrics, I provide excellence in patient care locally and abroad, and I oversee patient care services, infection control and antibiotic stewardship programs.

    I established and lead a global health research program, the International Enteric Vaccines Research Program (IEVRP), on the epidemiology, pathogenesis and vaccine development of childhood gastrointestinal infections. This program is dedicated to biomedical research, scientific training and international collaborations in Latin America, Southeast Asia and the United States. My collaborative scientific achievements with IEVRP include developing rapid diagnostic tools for diarrheal disease surveillance, identifying the most prevalent diarrheal pathogens and detecting emergent intestinal pathogens. My collaborators and I also worked on vaccine development research studies on pediatric infectious diseases associated with a high burden of disease. A long-term goal of these studies is to facilitate public health interventions for managing and preventing common infection diseases in children. Our studies on bacterial pathogenesis include genetic and phenotypic characterization of emergent E. coli pathogens and the role of surface proteins on gut colonization. Enterotoxigenic E. coli (ETEC) bacteria are important causes of diarrhea in travelers and children in the developing world. Our vaccine development research evaluates immunogenicity and immunoprotection of ETEC antigens delivered as live vaccines or purified proteins.

Clinical Expertise

  • Travel and tropical medicine, Pediatric HIV/AIDS, Pediatric viral infections

Education & Training

  • University of Washington
    University of WashingtonFellowship, Pediatric Infectious Diseases, 2004 - 2006
  • Sinai Hospital of Baltimore
    Sinai Hospital of BaltimoreResidency, Pediatrics, 2001 - 2004
  • National University of Colombia
    National University of ColombiaClass of 1987

Certifications & Licensure

  • GA State Medical License
    GA State Medical License 2023 - 2025
  • NC State Medical License
    NC State Medical License 2023 - 2025
  • NY State Medical License
    NY State Medical License 2016 - 2025
  • TN State Medical License
    TN State Medical License 2011 - 2018
  • IA State Medical License
    IA State Medical License 2006 - 2014
  • WA State Medical License
    WA State Medical License 2005 - 2006
  • American Board of Pediatrics Pediatrics
  • American Board of Pediatrics Pediatric Infectious Diseases

Awards, Honors, & Recognition

  • Community Service Award of Excellence for Promoting Inclusion and Cultural Diversity State University of New York (SUNY) at Buffalo, 2019

Publications & Presentations

PubMed

Press Mentions

  • Jacobs School of Medicine and Biomedical Sciences
    Jacobs School of Medicine and Biomedical SciencesAugust 26th, 2019

Grant Support

  • Studies on emergent E. coli pathogensNIAID, NIHPresent

Professional Memberships

Other Languages

  • Spanish, Portuguese, German